An earlier K33 report showed that NBIM’s BTC indirect exposure had expanded by more than 192% in the past year through H1 2025. According to K33 researcher Velte Lunde, the surge was largely fueled by ...

Eli Lilly's Mounjaro and Zepbound drove Q2 2025 revenue up 38% and EPS up 92% YoY. Read why LLY stock's recent 20% pullback ...

Atai Capital Management reports a 32.8% Q2 gain, reviews key portfolio moves and lessons from past missteps. Read the full letter for insights and strategy.